APA (7th ed.) Citation

H, S., X, S., H, L., Y, W., Y, Y., Y, X., . . . F, F. Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial. Dove Medical Press.

Chicago Style (17th ed.) Citation

H, Su, Shang X, Liu H, Wang Y, Yu Y, Xu Y, Jiang K, and Feng F. Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial. Dove Medical Press.

MLA (9th ed.) Citation

H, Su, et al. Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial. Dove Medical Press.